Can an 88-year-old male with impaired renal function, as indicated by a creatinine (Cr) level of 1.16, blood urea nitrogen (BUN) of 55, and glomerular filtration rate (GFR) of 60.6, undergo a computed tomography (CT) scan of the pelvis and abdomen with contrast, or should laboratory tests be repeated first?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

I would recommend proceeding with the contrast-enhanced CT scan for this 88-year-old male patient without repeating labs first, as the benefits of prompt diagnosis and treatment may outweigh the risks of contrast-induced acute kidney injury (CI-AKI) 1. The lab results from two weeks ago show a creatinine of 1.16 mg/dL, elevated BUN of 55 mg/dL, and a GFR of 60.6 mL/min/1.73m², which indicates borderline renal function. However, recent studies have shown that the risk of CI-AKI may be lower than previously thought, especially with the use of low-osmolal contrast agents and proper hydration 1. Some key points to consider:

  • The patient's age and renal function do not necessarily preclude the use of contrast-enhanced CT scans 1.
  • The use of contrast media can be beneficial in diagnosing and treating conditions such as diverticulitis, which is common in elderly patients 1.
  • Proper hydration and the use of low-osmolal contrast agents can minimize the risk of CI-AKI 1.
  • Non-contrast CT or alternative imaging modalities such as ultrasound or MRI may not provide the same level of diagnostic accuracy as contrast-enhanced CT scans 1. It is essential to weigh the potential benefits and risks of contrast-enhanced CT scans in this patient and to take steps to minimize the risk of CI-AKI, such as ensuring proper hydration and using the minimum necessary contrast dose.

From the Research

Patient's Current Condition

  • The patient is an 88-year-old male with a BMI of 22.3.
  • Lab results from two weeks ago: Cr 1.16, BUN 55, GFR 60.6.

Risk of Contrast-Induced Nephropathy (CIN)

  • According to 2, the incidence of CIN has been reported to range from 0% to 24%, and it is usually transient.
  • A study by 3 found that the overall incidence of CIN in patients with renal insufficiency was 6.1%, with no significant difference in the incidence of CIN compared to patients who did not receive contrast medium.
  • Another study by 4 reported a CIN incidence of 5.1% in patients with renal dysfunction, and found that cardiac dysfunction and ICU admission were associated with an increased risk of CIN.

Considerations for CT with Contrast

  • 5 suggests that minimizing the amount of contrast administered and providing adequate hydration are key to preventing CIN.
  • 6 notes that the true risk of CIN after intravenous contrast media administration is debatable, and that new studies have challenged the paradigm that CIN is a common occurrence with dire consequences.

Decision to Repeat Labs or Proceed with CT with Contrast

  • Given the patient's current GFR of 60.6, which is considered mild renal insufficiency, the risk of CIN may be relatively low, as suggested by 3.
  • However, the patient's age and potential comorbidities should be taken into consideration when deciding whether to repeat labs or proceed with the CT with contrast, as recommended by 2 and 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Contrast-induced nephropathy: Pathophysiology, risk factors, and prevention.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.